Baxter to Present at Barclays 27th Annual Global Healthcare Conference

Go back to Baxter to Present at Barclays 27th Annual Global Healthcare Conference

Goldman Sachs Reinstates Baxter International (BAX) at Buy

February 25, 2025 4:57 PM EST

Goldman Sachs analyst David Roman reinstates coverage on Baxter International (NYSE: BAX) with a Buy rating and a price target of $42.00.

The analyst comments "We reinstate our rating on BAX at Buy with a 12-month price target of $42. With... More